U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07226596) titled 'Non-Abstinence Outcomes in Methamphetamine Use Disorder' on Nov. 06.
Brief Summary: Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating the biopsychosocial benefits of reduced methamphetamine use. These data will be used to change current accepted methamphetamine treatment endpoints and accelerate identification of therapies for methamphetamine use disorder.
Study Start Date: Jan. 05, 202...